Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TU-100 for Gastrointestinal Recovery in Major Abdominopelvic Surgery
NCT07765589Phase 2Not yet recruiting
- Sponsor
- Tsumura & Co.
- Start
- Dec 2026
- Primary completion
- Jun 2028
01
Overview
Phase 2, randomised, double-blind trial in postoperative ileus (POI) comparing TU-100 7.5 g/day with Placebo (2 arms). Primary endpoint: Confirmed Gastrointestinal Recovery Response at 3 days. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
daikenchuto
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT07765589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765589.